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Abstract
Introduction: In chronic pain disorders, galanin (GAL) is able to either facilitate or inhibit nociception in the spinal cord but
the contribution of supraspinal galanin to pain signalling is mostly unknown. The dorsomedial nucleus of the hypothalamus
(DMH) is rich in galanin receptors (GALR) and is involved in behavioural hyperalgesia. In this study, we evaluated the
contribution of supraspinal GAL to behavioural hyperalgesia in experimental monoarthritis.
Methods:
(PWL) was assessed before and after DMH administration of exogenous GAL, a non-specific GALR antagonist (M40), a
specific GALR1 agonist (M617) and a specific GALR2 antagonist (M871). Additionally, the analysis of c-Fos expression after
GAL injection in the DMH was used to investigate the potential involvement of brainstem pain control centres. Finally,
electrophysiological recordings were performed to evaluate whether pronociceptive On- or antinociceptive Off-like cells in
the rostral ventromedial medulla (RVM) relay the effect of GAL.
Results: Exogenous GAL in the DMH decreased PWL in ARTH and SHAM animals, an effect that was mimicked by a GALR1
agonist (M617). In SHAM animals, an unselective GALR antagonist (M40) increased PWL, while a GALR2 antagonist (M871)
decreased PWL. M40 or M871 failed to influence PWL in ARTH animals. Exogenous GAL increased c-Fos expression in the
RVM and dorsal raphe nucleus (DRN), with effects being more prominent in SHAM than ARTH animals. Exogenous GAL
failed to influence activity of RVM On- or Off-like cells of SHAM and ARTH animals.
Conclusions: Overall, exogenous GAL in the DMH had a pronociceptive effect that is mediated by GALR1 in healthy and
arthritic animals and is associated with alterations of c-Fos expression in RVM and DRN that are serotonergic brainstem
nuclei known to be involved in the regulation of pain.
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Introduction
Galanin (GAL) is an injury-responsive peptide that is dramat-
ically upregulated in the dorsal root ganglia and spinal dorsal horn
interneurones during inflammation [1] or after nerve injury [2]. In
healthy animals, GAL’s action on nociceptive processing in the
spinal cord is bidirectional, with low concentrations eliciting
pronociceptive actions [3] and high concentrations promoting
antinociception [4]. Differences in spinal actions of GAL also vary
with the differential availability/activation of GAL receptor
(GALR) subtypes. GALR1 has an inhibitory action and is more
abundant than GALR2 (excitatory) and GALR3 (inhibitory) in the
superficial dorsal horn [5]. Despite the considerable number of
works evaluating its action in the peripheral nervous system and at
the spinal cord level, the role of GAL in pain modulation at the
supraspinal level is mostly unknown.
In basal conditions several studies showed that, both in humans
and rodents, GAL is expressed in the supraoptic nucleus, the
paraventricular nucleus of the hypothalamus, the dorsomedial
hypothalamic nucleus (DMH), the arcuate nuclei, the lateral
hypothalamic area, the locus coeruleus (LC), the amygdala (AMY)
and the median raphe nucleus [6], all areas involved in supraspinal
pain modulation [7–11]. In relation to receptor expression,
GALR1 is greatly expressed in the LC, dorsal raphe nucleus
(DRN), the paraventricular nucleus of the hypothalamus, DMH,
AMY, thalamus and medulla oblongata [12–15]. However, in the
AMY, GALR2/R3 are also significantly expressed [12]. Similarly,
all types of GAL receptors are expressed in the prefrontal cortex
and the hippocampus but to a lesser extent [12,14,15]. GALR2 is
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highly expressed in the hypothalamus, dentate gyrus, piriform
cortex and mammillary nuclei [14,15], while the expression of
GALR3 has been reported mainly in the hypothalamus (preoptic,
DMH, lateral and posterior hypothalamic, ventromedial and
premammillary nuclei) [15], the bed nucleus of the stria terminalis,
periaqueductal grey matter (PAG), lateral parabrachial nucleus
and medial reticular formation [16]. Again, most brain areas
mentioned above are involved in the codification and modulation
of nociceptive inputs [7,10].
The administration of exogenous GAL to the arcuate [17],
tuberomammillary [18], nucleus accumbens [19], central nucleus
of the AMY [20,21] and PAG [22] decreases nociception in
healthy rats, an effect that is mediated by GalR1 in rodents [23]. A
similar effect is observed in some pathological conditions, such as
acute inflammation or mononeuropathy [22], where the micro-
injection of supraspinal exogenous GAL also decreases nocicep-
tion. Albeit the apparent antinociceptive role of supraspinal GAL
in pain modulation, the intracerebroventricular administration of
a GALR1 agonist in rats increased c-Fos expression in the DMH
[24], an area that facilitates nociception by promoting behavioural
hyperalgesia [9,25]. As hyperalgesia is one of the hallmarks of
chronic pain, activation of the DMH promotes behavioural
hyperalgesia and GAL receptors are strongly expressed in the
DMH, here we evaluated the contribution of GAL receptors in the
DMH to the descending control of inflammatory hyperalgesia in
monoarthritis as well as nociception in healthy controls.
Methods
1. Animals, ethical issues and anaesthesia
The experiments were performed in adult male Wistar Han rats
with 175–250 g (Charles Rivers, Barcelona, Spain). A total of 96
animals (SHAM, n=48 and ARTH, n= 48) were used in the
experiments herein, 40 animals (SHAM, n=20 and ARTH,
n=20) were used in the behavioural assessment, 32 animals
(SHAM, n= 16 and ARTH, n= 16) in the c-Fos protocol and 24
animals (SHAM, n=12 and ARTH, n= 12) in the electrophys-
iological evaluation. Animals were randomly assigned two by two
to boxes upon arrival; a blue line was painted in the tail of one rat
and a red line in the tail of the other. Each box was numbered
from 1 to 48, no indication concerning if the animals were
assigned to the SHAM or ARTH group was displayed. The list
discriminating the boxes corresponding to the SHAM or ARTH
groups was kept by an independent party. Each animal was
considered a single unit within its experimental group. Animals
were housed two per cage, except for animals with chronic
intracerebral cannulae implanted that were housed individually.
Food and water were available ad libitum and animals were
maintained in a climate-controlled room, under 2262uC of
temperature, 5565% of humidity and under a 12 h light/dark
cycle with lights on at 8:00am. The experimental protocol
followed the European Community Council Directive 86/609/
EEC and 2010/63/EU concerning the use of animals for scientific
purposes and was approved by the Institutional Ethical Commis-
sion (Permit Number: 23248). All efforts were made to minimize
animal suffering and to use only the number of animals necessary
to produce reliable scientific data.
For cannula implantation the animals were anaesthetized i.p.
with a mixture 1:1.5 of ketamine (Imalgene, Merial, Oeiras,
Portugal) and medetomidine (Dorbene, Esteve, Carnaxide,
Portugal). After the surgical procedure, the anaesthesia was
reversed using atipamezole (Antisedan, Pfizer, Oeiras, Portugal,
i.p.) and the animals were monitored until fully awake (grooming
and eating).
Anaesthesia was induced by administering pentobarbitone
(50 mg/kg, i.p., Eutasil, CEVA, Alge´s, Portugal) and maintained
by infusing pentobarbitone (15–20 mg/kg/h, i.p.). The level of
anaesthesia was frequently assessed by determining behavioural
responses to noxious pinching. Body temperature was maintained
within physiological range with the help of a warming blanket (DC
Temperature Controller, FHC, Bowdoin, ME, USA). At the end
of the experiment, animals received a lethal dose of pentobarbi-
tone.
2. Induction of arthritis
The induction of monoarthritis (ARTH) was performed four
weeks before the actual experiments, as described in detail
elsewhere [9,26]. In order to maintain the researcher blind in
relation to whether the animals from a specific box were assigned
to the SHAM or ARTH groups, the animals were anaesthetized
(section 2.1) by a third party in an adjacent room and then brought
to the chirurgical table in groups of two for the injection of SAL or
K/C in the right knee joint. Briefly, in anaesthetised animals a
mixture of 3% kaolin and 3% carrageenan (K/C, Sigma-Aldrich,
St. Louis, MO, USA) dissolved in saline was injected into the
synovial cavity of the right knee joint at a volume of 0.1 mL. This
model produces mechanical hyperalgesia, which begins a few
hours after surgery and extends up to 8 weeks [27]. After the
procedure, animals returned to the adjacent room, the anaesthesia
was reversed and animals were monitored until fully recovered
(eating and grooming). At the end of the induction session all boxes
were returned to the animal house. In each animal, development
of arthritis was verified again 1 h prior to each behavioural session.
While confirming the arthritic status of the animals, through the
flexion and extension of the right leg, the experimenter was
handed the animals by a third party without any specific order and
without prior knowledge of the box number. Only those rats that
vocalized every time after five flexion–extension movements of the
knee joint were considered to have arthritis, and they were
included in the ARTH group. SHAM animals were injected with
0.1 mL saline in the synovial cavity of the right knee joint. SHAM
animals did not vocalize to any of the five consecutive flexion–
extension movements of the knee joint. After the test, the animals
were returned to their home cages by a person other than the
evaluator.
3. Behavioural assessment of nociception
All behavioural tests were performed during the day time,
starting at 9:30am and ending at 1:30pm after which the animals
were returned to the animal house.
3.1 Mechanical hyperalgesia. The application of noxious
pressure to the primary site of injury is a classical approach to
measure mechanical hyperalgesia [28], both in humans and
animals [29]. Here, the pressure application measurement (PAM;
Ugo Basile, Comerio, Italy) method was used. It allows an
accurate behavioural measurement of mechanical hypersensitivity
in rodents with chronic inflammatory joint pain [30] by the
application of a force range of 0–1500 g. To perform the test and
with the animal securely held, the force transducer unit (fitted to
the experimenter’s thumb) is placed on one side of the animal’s
knee joint and the forefinger on the other and an increasingly force
is applied across the joint until a behavioural response is observed
(limb-withdrawal, freezing of whisker movement, wriggling or
vocalization) with a cut-off of 5 s. The peak force applied
immediately prior to the behavioural response is recorded as the
response threshold (RT). RT was measured twice in the ipsilateral
and contralateral limbs at 1 min intervals. The mean RTs were
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calculated per animal. At the end of the session animals were
returned to their home cage.
3.2 Thermal hyperalgesia (heat). Heat hyperalgesia was
evaluated using the Hargreaves test [31]. The rats were habituated
to the experimental conditions by allowing them to spend 1–2 h
daily in the experimental room for the three days preceding any
behavioural tests [9]. For assessing heat hyperalgesia, a radiant
heat source was placed under the hindpaws in awake animals and
the time spent between the heat application and the withdrawal
response (Plantar Test Instrument, Model 37370, Ugo Basile,
Varese, Italy) was registered as the paw-withdrawal latency (PWL).
In each session, the PWL was assessed prior to drug administration
in the DMH and 20 min after. In each time point, the PWL was
repeated twice at an interval of 1 min and the mean of these values
was used in further calculations. Cut-off time was 15 s.
4. Procedures for intra-DMH microinjections
Before the placement of the guide cannulas the animals were
anaesthetized (section 2.1) by a third party in an adjacent room
and then brought to the chirurgical table one at the time. For
intra-DMH drug administration, four weeks before the actual
experiments (at the same time that arthritis was induced), animals
were anaesthetised and placed in a stereotaxic frame, and one
stainless steel guide cannula (26 gauge; PlasticsOne, Roanoke, VA,
USA) was then implanted in the DMH according to the
coordinates of the atlas by Paxinos and Watson [32]. The tip of
the guide cannula was positioned 1 mm above the desired
injection site in the DMH [AP, 23.24 mm from bregma; LM,
0.4 mm lateral from the midline (right side); DV, 7.5 mm below
the surface of the skull]. The guide cannula was kept in place
through the use of two dental screws and dental cement. A dummy
cannula was inserted into the guide cannula to close the top. After
the procedure, the anaesthesia was reversed and animals were
monitored until being fully recovered (eating and grooming) in the
adjacent room and returned to the animal house.
In order for the experimenter to remain blinded in relation to
which animals were SHAMs or ARTHs, prior to the beginning of
the behavioural session, the cards displaying the number of the
box were substituted by cards displaying letters. Test drugs were
administered in the DMH through a 33-gauge injection cannula
(PlasticsOne) inserted into and protruding 1 mm beyond the tip of
the guide cannula. The microinjection was made using a 10.0-mL-
Hamilton syringe connected to the injection cannula by a
polyethylene catheter (PE-10; Plastics One). The injection volume
was 0.5 mL and therefore, the spread of the injected drugs within
the brain was expected to be 1 mm [33]. The efficacy of injection
was monitored by observing the movement of a small air bubble
through the tubing. The injection lasted 20 s and the injection
cannula was left in place for additional 30 s to minimize the return
of drug solution back to the injection cannula. Brain injection sites
were histologically verified from post-mortem sections and plotted
on standardized sections from the stereotaxic atlas [32] (Fig. 1).
After the completion of the tests and animals were returned to the
animal house, the cards were switch again. The attribution of the
letter cards was recorded in a lab book separate from the one used
to register the results. The order of attribution of the letter cards
was random and changed in each experimental session. The order
of the administration of the drugs to each animal was defined at
the beginning of the experiment to avoid potential confounding
effects related to this parameter. The results of the tests were only
associated with the respective animal after the end of the
experiment.
5. Drugs
Solutions for drug administration in the DMH were prepared in
sterilized saline 0.9% (Unither, Amiens, France; pH 7.2). All the
experimental drugs used in this work were acquired from Tocris
(Bristol, UK). Each injection had a volume of 0.5 mL and
contained either GAL (1.0 nmol), a non-specific GAL receptor
antagonist (M40, 1.0 nmol), a specific GALR1 agonist (M617,
1.0 nmol) or a specific GALR2 antagonist (M871, 1.0 nmol)
[17,20,23]. Control injections were performed with SAL in order
to avoid any confounding effect that might result from injecting
the liquid itself.
6. Course of the pharmacological study
Four weeks following induction of arthritis and insertion of the
guide cannula for DMH injections, the efficacy of DMH-induced
phasic and tonic modulation of nociception was determined by
assessing the effect of DMH injection of exogenous GAL, M40,
M671 and M871 upon the PWL in awake SHAM and ARTH
animals. SAL was used in control injections. The latency of the
withdrawal response was assessed 20 min [18,34] following the
intra-DMH injections. The interval between behavioural assess-
ments of different drug treatment conditions in the same animal
was at least two days. The order of testing different drugs varied
between the animals.
7. Recording of neuronal activity in nociceptive RVM cells
For the electrophysiological study, animals were removed from
the animal house in a random order, one per day, already
anaesthetized, by a person other than the experimenter. Anaes-
thesia (section 2.1) was administered at 9:30am, the electrophys-
iological recordings started between 10am and 10:30 am and
lasted for 3 h. The order of the administration of the drugs varied
between the animals. The electrophysiological recordings of the
activity of RVM neurones followed a protocol described in Pinto-
Ribeiro and colleagues [9]. In anaesthetised animals, a recording
electrode was placed in the RVM (AP: 5.88 mm rostral to the
interaural line, ML: 20.6 to 0.6 mm lateral from the midline, and
DV: 10.0 mm below the surface of the skull) [32]. Single neurone
activity was recorded extracellularly with tungsten electrodes (tip
impedance 3–10 MV at 1 kHz), the signal was amplified and
filtered and data sampling was performed through a CED Micro
1401 interface and Spike 2 software (Cambridge Electronic
Design, Cambridge, UK).
Recording of RVM neurones was started after the animal was
under light anaesthesia; i.e., the animals gave a brief withdrawal
response to noxious pinch, but the pinch did not produce any
longer lasting motor activity, nor did the animals have spontane-
ous limb movements. RVM neurones were classified based on
their response to noxious heating of the tail with a tail-flick device
(Ugo Basile). Heat stimulation of the tail was applied during 10 s.
Functional classification of RVM neurones followed the scheme
developed earlier by Fields and colleagues [35] and by Fields and
Heinricher [36]. The neurones whose firing activity increased
during heat stimulation of the tail were considered On-cells, those
decreasing its activity were classified as Off-cells and finally, cells
displaying only a negligible (,10%) or no alteration in discharge
rates during noxious stimulation were considered Neutral-cells and
were not analysed in this study. However, a significant difference
with the classification scheme of Fields [35] is that in the present
study the noxious stimulus-induced withdrawal reflex was not
taken into account in the classification. Therefore, as in previous
studies, RVM cells are here called On-like and Off-like cells
[9,37,38] rather than On- or Off-cells.
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The characterization of the response properties of RVM cells
consisted of the following assessments performed successively: (i)
spontaneous activity; (ii) response to heating of the tail; (iii)
recovery to the spontaneous activity level.
It should be noted that when analysing responses of RVM
neurones to peripheral stimulation, the baseline discharge
frequency (recorded just before the stimulation) was subtracted
from the discharge frequency assessed during the stimulation using
the following formula:
Evoked response
~ cell activity during acute noxious stimulationð Þ
{ basal cell activity prior to stimulus applicationð Þ
Thus, positive values represent an increase and negative ones
represent a decrease in cell activity evoked by peripheral
stimulation.
During the recordings, animals also had a guide cannula
implanted for drug administration into the DMH. After
determining the baseline spontaneous activity of RVM cells and
their baseline noxious-evoked responses to peripheral stimulation,
either exogenous GAL or a non-specific GALRs antagonist (M40)
were microinjected in the DMH, in order to assess its phasic or
tonic effect, respectively, upon the discharge rate of RVM
neurones. All results from drug administrations were plotted for
the variation in activity comparing baseline (before drug admin-
istration) and values obtained 20 min after the injection into the
DMH. The results of the electrophysiological analysis were only
associated with the respective animal after all recordings were
performed.
8. Course of the electrophysiological study
Electrophysiological recordings of RVM neurones (SHAM: On-
like cells, n = 58 and Off-like cells, n = 40; ARTH: On-like cells,
n = 46 and Off-like cells, n = 47) were performed under pentobar-
bitone anaesthesia four weeks after the administration of K/C
Figure 1. Anatomical confirmation of drug injection sites in the dorsomedial nucleus of the hypothalamus (DMH). (A)
Photomicrograph of an example of the drug injection site in the right DMH of the rat brain (AP: 23.24 mm from bregma) superimposed with
the appropriate plate of the Paxinos and Watson (2007) stereotaxic atlas. (B) Schematic representation of injection sites in the DMH during the
behavioural study. The coordinates for the injection sites are as follow 23.00 mm, 23.12 mm, 23.24 mm and 23.36 mm from bregma. (C)
Schematic representation of injection sites in the DMH during the protocol for the induction of c-Fos expression. The coordinates for the injection
sites are as follow23.00 mm,23.12 mm,23.24 mm and23.36 mm from bregma. (D) Schematic representation of injection sites in the DMH during
the electrophysiological study. The coordinates for the injection sites are as follow 23.00 mm, 23.12 mm, 23.24 mm, 23.36 mm and 23.48 mm
from bregma. (Grey dots correspond to injection sites in the DMH of control (SHAM) animals and black dots show injection sites in the DMH of
arthritic (ARTH) animals; grey and black crosses correspond to injection sites outside the DMH of SHAM and ARTH animals, respectively) ArcD- arcuate
hypothalamic nucleus, dorsal; ArcL- arcuate hypothalamic nucleus, lateral; ArcM- arcuate hypothalamic nucleus, medial; DMC - dorsomedial
hypothalamic nucleus, compact; DMD – dorsomedial hypothalamic nucleus, dorsal; DMV - dorsomedial hypothalamic nucleus, ventral; VMHDM -
ventromedial hypothalamic nucleus, dorsomedial; VMHSh - ventromedial hypothalamic nucleus, shell; VMHVL - ventromedial hypothalamic nucleus,
ventrolateral.
doi:10.1371/journal.pone.0113077.g001
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(ARTH) or SAL (SHAM) in the right knee of animals. In RVM
recordings, the response properties of nociceptive neurones were
assessed by determining their spontaneous activity and the
response to noxious heating of the tail. Search for the next
neurone to be studied started about 30 min after testing of the
previous one was completed. At the end of the recording session,
electrolytic lesions were made in the recording sites, the animals
were given a lethal dose of pentobarbitone and the brains were
removed for histological verification of the recording and injection
sites.
9. c-Fos study
For the c-Fos induction protocol, animals were removed from
the animal house in a random order, one per day, already
anaesthetized, by a person other than the experimenter. Anaes-
thesia (section 2.1) was administered at 9:30 am; the protocol
started between 10am and 10:30am and lasted for 2 h. To
evaluate changes in brain activation after exogenous GAL
administration in the DMH and/or peripheral noxious stimulation
in SHAM and ARTH animals, c-Fos immunoreaction was
performed following the protocol described elsewhere [39].
Animals were held in a stereotaxic frame. For drug administration,
a guide cannula was placed in the DMH according to the
coordinates of the atlas by Paxinos and Watson [32] and one of the
following protocols was performed: (i) SAL microinjection in the
DMH of SHAM animals; (ii) exogenous GAL microinjection in
the DMH of SHAM animals; (iii) SAL microinjection in the DMH
and extension of right limb of SHAM animals; (iv) exogenous GAL
microinjection in the DMH and extension of right limb of SHAM
animals; (v) SAL microinjection in the DMH of ARTH animals;
(vi) exogenous GAL microinjection in the DMH of SHAM
animals; (vii) extension of right limb of ARTH animals; (viii)
exogenous GAL microinjection in the DMH and extension of
right limb of ARTH animals. Two exogenous GAL (or SAL) doses
were injected in the DMH with a 15 min interval (Fig. 2).
Extension of the paw was performed 5 times every 2 minutes for
2 h. Two hours after the first injection and first knee extension
(beginning of the protocol), the animals were transcardially
perfused with 4% paraformaldehyde in 0.1 M phosphate buffer
saline (PBS, pH=7.4), brains were removed and then post-fixed
overnight in the same fixative and kept in a solution of 8% sucrose
in PBS. One in three coronal vibratome (Leica, Carnaxide,
Portugal) sections (50 mm thick) were treated with a solution of
3.3% H2O2 in PBS (30 min) to inhibit endogenous peroxidase
activity, and then sequentially washed thrice (10 min) in PBS and
PBS-Triton (PBS-T; 0.3% triton X-100; Sigma-Aldrich, Sintra,
Figure 2. Schematic representation of the experimental design. In all experiments, animals were divided in two groups, control (SHAM) when
injected with saline and arthritic (ARTH) when injected with a mixture of kaolin and carrageenan in the synovial capsule of the right knee joint. Three
days after the intrasynovial injection, arthritis was confirmed by performing five consecutive movements of flexion/extension of the knee (dashed
line). Animals in the ARTH group developed a clear swelling of the treated knee joint and all gave a vocalization response during a minor extension
and flexion of the affected limb by the experimenter. SHAM animals displayed no obvious swelling of the knee joint and did not vocalize when the
limb was flexed. Four weeks after the induction of monoarthritis animals were tested in three independent experiments. In experiment 1, the
Hargreaves test was used to study the effect of exogenous galanin (GAL), a non-specific GAL receptor antagonist (M40), a specific GAL receptor-1
agonist (M617) and a specific GAL receptor-2 antagonist (M871) in the dorsomedial nucleus of the hypothalamus (DMH) upon paw-withdrawal
latency (PWL) (n = 20 per experimental group). In each animal, the development of arthritis was confirmed again 1 h prior to each behavioural session
by performing five consecutive movements of flexion/extension of the knee. During the experimental sessions, PWL was assessed before and 20 min
after the administration of the drugs to the DMH. In experiment 2, two days prior the c-Fos study, the pressure application measurement (PAM) test
was performed to confirm the arthritic state of the animals. c-Fos expression was evaluated in SHAM and ARTH animals after exogenous GAL or saline
(SAL) administration in the DMH, peripheral noxious mechanical stimulation and the simultaneous application of noxious mechanical stimulation
after the microinjection of exogenous GAL in the DMH (n= 16 per experimental group). Peripheral stimulation was applied each 2 minutes during
2 hours and two drug injections were made in the DMH, one at the beginning and another 15 minutes after the beginning of peripheral stimulation.
Neurones expressing c-Fos were quantified bilaterally in the ventrolateral periaqueductal grey matter (vlPAG), locus coeruleus (LC), dorsal raphe
nucleus (DRN) and rostral ventromedial medulla (RVM). In experiment 3, RVM neurones were recorded before and after the administration of
exogenous GAL and M40 in the DMH. The assessment of neuronal activity includes a preliminary evaluation of spontaneous and noxious-evoked
activity followed by the recording of these parameters 20 min after drug administration to the DMH (n= 12 animals per experimental group). PI – Pre-
injection; Inj – Injection; SAL - saline microinjection in the dorsomedial nucleus of the hypothalamus; GAL - galanin microinjection in the dorsomedial
nucleus of the hypothalamus; SAL+STI – saline microinjection in the dorsomedial nucleus of the hypothalamus and extension of right limb; GAL+STI –
galanin microinjection in the dorsomedial nucleus of the hypothalamus and extension of right limb.
doi:10.1371/journal.pone.0113077.g002
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Portugal). Sections were then incubated in a blocking solution of
2.5% fetal bovine serum (FBS; Biochrom, Cambridge, United
Kingdom) in PBS for 2 h, followed by the incubation overnight at
4uC in rabbit anti-Fos antibody (1:2000 in PBST and 2% FBS;
Calbiochem, Merck, Alge´s, Portugal). The following day, after
three washes (10 min) in PBST, sections were incubated in
biotinylated polyclonal swine anti-rabbit antibody (1:200 in PBST;
Dako, Denmark) for 1 h and again washed thrice (10 min) in PBS-
T. Sections were then incubated in avidin–biotin complex (ABC;
1:200 in PBST; Vectastain, Vector Laboratories, Peterborough,
USA) for 1 h followed by a series of washing steps with PBST
(twice, 10 min), PBS (twice, 10 min) and Tris-HCl (0.05 M,
pH 7.6) (twice, 10 min). Finally, sections were stained with
diaminobenzidine (0.0125% in a solution of Tris-HCl with
0.02% H2O2; Sigma Aldrich) and washed twice (10 min) with
Tris-HCl and PBS. After staining, the sections were mounted on
SuperFrost slides (Braunschweig, Germany). c-Fos levels were
determined by counting the number of Fos-immunoreactive
neurones occurring bilaterally in the brainstem with the aid of a
Stereo Investigator 10 Software (Microbrigthfield Bioscience,
Madgedurg, Germany) using a video camera (Microbrigthfield
Bioscience) attached to a microscope (BX51, Olympus Iberia,
Lisboa, Portugal).
10. Statistics
For the effect of drugs upon PWL, the minimum number of
animals needed was determine a` priori using the G power software
(version 3.1.9.2, University of Kiel, Germany) considering a
ANOVA-2-way test, a err probability of 0.05, power of 0.95 and
an effect size of 0.80 was n= 23. For the effect of drugs upon RVM
neuronal activity, the minimum number of animals needed was
determine a` priori using the G power software considering a
ANOVA-2-way test, a err probability of 0.05, power of 0.95 and
an effect size of 0.80 was n= 28. For the effect of drugs upon c-Fos
expression, the minimum number of animals needed was
determine a` priori using the G power software considering a
ANOVA-2-way test, a err probability of 0.05, power of 0.95 and
an effect size of 0.80 was n= 32. The results of the RT analysis
correspond to the mean 6 SD of raw data; no method of data
normalization was used. To assess the effect of the drugs upon
PWL for each behavioural session, the value of the basal
withdrawal latency (withdrawal latency prior to drug administra-
tion) was subtracted from the value of the withdrawal latency at
the peak effect of the drug, a negative value indicated the
withdrawal latency decreased while a positive value corresponded
to an increase in withdrawal latency after drug administration to
the DMH. To perform this evaluation, raw data was used. To
assess the effect of the drugs upon spontaneous neuronal activity,
the value of the activity of RVM On- and Off-like cells without
noxious peripheral stimulation prior to the administration of drugs
in the DMH was subtracted from the activity of these cells without
noxious peripheral stimulation at the peak effect of the drug.
Similarly, to assess the effect of the drugs upon the noxious-evoked
neuronal activity the value of the activity of RVM On- and Off-
like cells during noxious peripheral stimulation prior to the
administration of drugs in the DMH was subtracted from the
activity of these cells during noxious peripheral stimulation at the
peak effect of the drug. Only raw data was used in this analysis. To
compare the level of c-fos in each area, the total number of cells
stained was registered per area studied and only raw data was used
in this analysis. The GraphPad Prism 6 software (GraphPad
Software Inc, La Jolla, CA, USA) was used to perform the
statistical analysis. The comparison of differences between RT in
the PAM test and between the baseline of RVM neuronal
spontaneous and heat-evoked activities of SHAM and ARTH
animals were performed using a student’s t-test for unpaired data.
To compare differences in RT between the ipsilateral and the
contralateral side in SHAM and ARTH animals a student’s t-test
for paired data was used. All other comparisons between groups
were performed using a two-way ANOVA followed by a
Bonferroni correction for multiple comparisons post-hoc test.
Statistical significance was accepted for P,0.05.
Results
1. Monoarthritic animals developed ipsilateral
mechanical allodynia
Three days after the intrasynovial injection, all animals in the
ARTH group developed a clear swelling of the treated knee joint
and all gave a vocalization response during a minor extension and
flexion of the affected limb by the experimenter. SHAM animals
displayed no obvious swelling of the knee joint and did not vocalize
when the limb was flexed.
Mechanical hyperalgesia in the knee joint was assessed by
determining RT to mechanical pressure over the knee joint. No
differences were found between the RT of the ipsilateral and
contralateral hindpaws in SHAM animals (t7 = 1.535, P=0.169)
while in ARTH animals the ipsilateral RT was significantly lower
than the contralateral (t7 = 3.377, P=0.0118). No differences were
found between the contralateral RT of SHAM and ARTH
animals (t14 = 0.000, P.0.999). Four weeks after induction of
monoarthritis, RT was significantly different between SHAM and
ARTH animals (t14 = 2.883, P=0.012). This result indicates that
K/C induced a significant RT decrease, i.e., mechanical
hyperalgesia (Fig. 3).
2. Exogenous GAL in the DMH decreases paw-withdrawal
latency, an effect reversed by the administration of a GAL
receptors antagonist
To investigate a possible role of supraspinal GAL in phasic and
tonic pain facilitation in SHAM and ARTH animals, paw
withdrawal latencies (PWL) were assessed after exogenous GAL
or M40 microinjection, respectively, in the DMH. The PWL of
SHAM and ARTH animals 20 min after exogenous GAL
microinjection in the DMH was significantly decreased when
compared with SAL injection (main effect of the drug:
F1,76 = 61.880, P,0.001). The exogenous GAL-induced decrease
in PWL was of the same magnitude in the SHAM and ARTH
groups (main effect of the group: F1,76 = 2.704, P=0.104). Post
hoc tests confirmed that the PWL of SHAM and ARTH animals
treated with exogenous GAL was significantly lower than the PWL
of SHAM and ARTH animals treated with SAL (Fig. 4A).
Non-specific inhibition of GAL receptors induced by adminis-
tration of M40 in the DMH significantly altered the PWL when
compared with SAL injection (main effect of the drug:
F1,76 = 13.830, P,0.001). The effect of M40 was significantly
different between SHAM and ARTH animals (main effect of the
group: F1,76 = 10.070, P=0.002). The M40-induced effect on
PWL varied with the experimental group (interaction between
group and drug: F1,76 = 8.048, P=0.006). Post hoc tests indicated
that M40 significantly increased PWL in SHAM animals, but did
not alter PWL in ARTH animals (Fig. 4B).
3. Nociceptive facilitation after exogenous GAL in the
DMH is mediated by GAL receptors type-1
To determine which GAL receptor is involved in pain
facilitation induced by exogenous GAL in the DMH, PWL was
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assessed after the administration of M617 (a specific agonist of
GAL receptor type-1 - GalR1) and M871 (a specific antagonist of
GAL receptor type-2 - GalR2) into the DMH. Twenty minutes
after microinjecting M617 in the DMH, PWL was significantly
decreased when compared with SAL injection (main effect of the
drug: F1,76 = 39.530, P,0.001). The effect of M617 was not
different between SHAM and ARTH groups (main effect of the
group: F1,76 = 0.357, P=0.552). Post hoc tests confirmed that
PWL significantly decreased after M617 administration in the
DMH both in SHAM and ARTH animals when compared to
PWL after SAL administration (Fig. 4C).
Figure 3. Response threshold. Four weeks after the induction of monoarthritis in the right hind limb, no differences were observed in the
response threshold (RT) of the contralateral hindpaws between control (SHAM) and arthritic (ARTH) animals (A) in the pressure application
measurement. In the ipsilateral side however ARTH animals displayed a decrease in RT during the pressure application measurement when compared
to SHAM animals (B). Mean response threshold is presented as mean + SEM. (*P,0.05, t-test for unpaired data). gf – gram force.
doi:10.1371/journal.pone.0113077.g003
Figure 4. Paw-withdrawal latency after drug administration in the dorsomedial nucleus of the hypothalamus (DMH). In this
experiment the analysis of the paw-withdrawal latencies in control (SHAM) and arthritic (ARTH) animals was performed 20 minutes after the
intracerebral microinjection of either exogenous galanin (GAL) (A), a non-specific antagonist of GAL receptors (M40; B), a specific agonist of GAL
receptor-1 (M617; C) or a specific antagonist of GAL receptor-2 (M871; D). Note that the pronociceptive action of exogenous GAL administration in
the DMH in SHAM and ARTH animals (A) is only mimicked by the microinjection of M617 (C). Mean response latency is presented as mean + SEM.
(*P,0.05, **P,0.01, ***P,0.001, t-test with a Bonferroni correction for multiple comparisons).
doi:10.1371/journal.pone.0113077.g004
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Administration of M871 in the DMH had a significant effect on
PWL (main effect of the drug: F1,76 = 29.820, P,0.001), and the
effect of M871 varied with the experimental group (interaction
group x drug: F1,76 = 5.089, P=0.027). Post hoc tests showed that
M871 significantly decreased the PWL in SHAM animals but did
not alter significantly the PWL of ARTH animals (Fig. 4D).
4. Expression of c-Fos in brainstem areas involved in pain
control is altered by exogenous GAL in the DMH
Descending pain modulatory drive from the forebrain to the
spinal cord may be relayed by multiple areas in the brainstem. To
determine which brainstem areas mediate exogenous GAL-driven
descending pain modulatory effects originating in the DMH, c-Fos
expression was investigated in caudal brain areas that not only
expressed GAL and/or its receptors but that are also involved in
the descending modulation of nociception. Hence, we compared
changes in c-Fos expression in the ventrolateral periaqueductal
grey matter (VLPAG), the LC, the dorsal raphe nucleus (DRN)
and the rostral ventromedial medulla (RVM) between SHAM and
ARTH animals after (i) SAL microinjection in the DMH of
SHAM animals; (ii) GAL microinjection in the DMH of SHAM
animals; (iii) SAL microinjection in the DMH and extension of
right limb of SHAM animals; (iv) GAL microinjection in the
DMH and extension of right limb of SHAM animals; (v) SAL
microinjection in the DMH of ARTH animals; (vi) GAL
microinjection in the DMH of SHAM animals; (vii) extension of
right limb of ARTH animals; (viii) GAL microinjection in the
DMH and extension of right limb of ARTH animals.
Expression of c-Fos following injection of SAL in the DMH was
considered to represent basal activation. The number of c-Fos
positive neurones in the contralateral RVM varied with the
stimulation protocol used (main effect of the protocol:
F3,24 = 22.570, P,0.001) with different effects on SHAM and
ARTH animals (interaction group x protocol: F3,24 = 42.280, P,
0.001). Post-hoc testing showed that exogenous GAL in the DMH
significantly increased c-Fos expression when compared to SAL-
injected animals in both experimental groups, although a higher
expression was observed in ARTH animals (Fig. 5A). The flexion-
extension protocol (SAL+STI) increased c-Fos expression in
SHAM animals when compared to SAL and GAL administration
while it decreased its expression in ARTH animals when
compared to GAL-Injected ARTH. The simultaneous infusion
of GAL in the DMH and flexion-extension of the injected limb
decreased c-Fos expression in SHAM when compared with its
expression after the flexion-extension protocol and in ARTH
when compared with GAL-injected ARTH (Fig. 5A). Similarly,
in the ipsilateral RVM, the number of cells activated was
significantly different depending on the protocols (main effect of
the protocol: F3,24 = 70.240, P,0.001), an effect that varied with
the experimental group (interaction group x protocol:
F3,24 = 20.240, P,0.001). Post-hoc testing showed that GAL in
the DMH increased the number of c-Fos expressing cells in both
experimental groups when compared to SAL-injected animals,
while its expression was different between SHAM and ARTH
animals after repeated flexion-extension of the injected limb, with
increased c-Fos expression in SHAM animals alone when
compared with SAL and GAL-injected SHAM (Fig. 5B). The
simultaneous injection of GAL in the DMH and flexion-extension
of the injected limb significantly decreased the number of c-Fos
positive cells in SHAM when compared to the flexion-extension
protocol and in ARTH animals when compared with GAL
administration and the flexion-extension protocols (Fig. 5B).
The number of c-Fos expressing neurones in the contralateral
LC did not vary with the stimulation protocols (main effect of the
protocol: F3,24 = 0.413, P=0.745) although it was significantly
different between experimental groups (main effect of the group:
F3,24 = 16.410, P,0.001). Post-hoc testing did not show a specific
alteration between each stimulation protocol (Fig. 5C). In the
ipsilateral LC, the number of c-Fos positive cells varied with the
stimulation protocol (main effect of the protocol: F3,24 = 7.462,
P=0.001), an effect that depended on the experimental group
(interaction group x protocol: F3,24 = 14.310, P,0.001). Post-hoc
testing showed an increase in the number of c-Fos expressing
neurones after the simultaneous infusion of GAL in the DMH and
flexion-extension of the injected limb in ARTH animals when
compared with the same protocol in SHAM and with the SAL/
GAL/flexion-extension protocols in ARTH (Fig. 5D).
In the contralateral vlPAG, the number of c-Fos expressing cells
varied with the stimulation protocol (main effect of the protocol:
F3,24 = 19.200, P,0.001), an effect that depended on the
experimental group (interaction group x protocol: F3,24 = 40.030,
P,0.001). Post-hoc testing showed a significant increase in the
number of c-Fos positive cells in ARTH animals when compared
to SHAM and after exogenous GAL in the DMH of SHAM
animals when compared to SAL injected SHAM (Fig. 5E). In
addition, in ARTH animals the number of c-fos expressing
neurones was significantly lower in all protocols when compared to
SAL injected ARTH animals (Fig. 5E). Similarly, the number of
cells activated in the ipsilateral vlPAG was different after the
stimulation protocols (main effect of the protocol: F3,24 = 22.920,
P,0.001) and depended on the experimental group (interaction
group x protocol: F3,24 = 47.100, P,0.001). Post-hoc testing
(Fig. 5F) showed increased c-Fos expression in SAL-injected
ARTH animals when compared with SAL-injected SHAM. GAL
in the DMH significantly increased c-Fos expression in SHAM
animals while it significantly decreased its expression in ARTH
animals. c-Fos expression after the flexion-extension of the injected
limb was not significantly different when compared to SAL-
injected SHAM although it was significantly decreased when
compared to GAL-injected SHAM (Fig. 5F). This protocol also
significantly decreased c-Fos expression in ARTH animals when
compared to SAL-injected ARTH although its expression was
significantly higher when compared to GAL-injected ARTH. The
simultaneous infusion of GAL in the DMH and flexion-extension
of the injected limb did not significantly alter c-Fos expression
when compared to SAL-injected SHAM but was significantly
decreased when compared to its expression after GAL injection in
the DMH. In ARTH animals, c-Fos expression was significantly
decreased after the simultaneous infusion of GAL in the DMH and
flexion-extension of the injected limb when compared to SAL-
injected ARTH and the flexion-extension protocol (Fig. 5F).
Finally, In the DRN, the number of c-Fos positive cells varied
with the stimulation protocol (main effect of the protocol:
F3,24 = 24.690, P,0.001) and this effect was dependent of the
experimental group (interaction group x protocol: F3,24 = 14.140,
P,0.001). Post-hoc testing showed an increased DRN activation
after GAL in the DMH in both experimental groups when
compared to SAL-injected animals (Fig. 5G). The flexion-
extension of the injured limb significantly increased c-Fos
expression in SHAM animals when compared to ARTH animals
and when compared with SAL- and GAL-injected SHAM. The
simultaneous infusion of GAL in the DMH and flexion-extension
of the injected limb increased c-Fos expression in SHAM animals
when compared to ARTH and to its expression after SAL, but
decreased when compared to the flexion-extension protocol.
Additionally, it decreased c-Fos expression in ARTH animals
when compared to GAL-injected ARTH (Fig. 5G).
Role of Supraspinal Galanin in Hyperalgesia in the Rat
PLOS ONE | www.plosone.org 8 November 2014 | Volume 9 | Issue 11 | e113077
Role of Supraspinal Galanin in Hyperalgesia in the Rat
PLOS ONE | www.plosone.org 9 November 2014 | Volume 9 | Issue 11 | e113077
5. The activity of pain modulatory On- or Off-like cells in
the RVM is not altered by exogenous GAL in the DMH
To evaluate the effect of exogenous GAL administration in the
DMH upon the activity of RVM neurones, the spontaneous and
heat-evoked activities of presumably pronociceptive RVM On-like
cells and antinociceptive RVM Off-like cells were recorded in
SHAM and ARTH animals before and after the administration of
exogenous GAL, M40 or SAL.
Before drug administration, the spontaneous activity of RVM
On-like cells was significantly decreased in ARTH animals when
compared to SHAM animals (Table 1). The magnitude of the
response evoked by noxious heating of the tail in RVM On-like
cells was not different between SHAM and ARTH animals. In
RVM Off-like cells, the spontaneous activity before drug
treatments was significantly decreased in ARTH animals when
compared to SHAM animals. Similarly, the magnitude of the
heat-evoked response in RVM Off-like cells of ARTH animals was
significantly lower when compared to that in SHAM animals
(Table 1).
Microinjection of drugs into the DMH did not alter the
spontaneous activity of RVMOn-like cells (main effect of the drug:
F2,98 = 0.262, P=0.770). Overall, after drug injection, On-like cell
spontaneous activity was different between ARTH and SHAM
animals (main effect of the group: F1,98 = 6.510, P=0.012)
(Fig. 6A), although post-hoc tests failed to show a significant
difference between experimental groups at a specific time point.
The administration of drugs to the DMH did not alter the
spontaneous activity of RVM Off-like cells (main effect of the
drug: F2,81 = 0.616, P=0.543) and the spontaneous activity was
not different between experimental groups (main effect of the
group: F1,81 = 1.200, P=0.277) (Fig. 6B) 20 min after drug
administration.
Microinjection of drugs into the DMH altered the heat-evoked
activity of RVM On-like cells (main effect of the drug:
F2,98 = 5.010, P=0.009) but this effect did not vary with the
experimental group (interaction group x drug: F2,98 = 1.318,
P=0.272). Post hoc testing failed to find significant drug
treatment-induced effects on the heat-evoked response of On-like
cells (Fig. 6C). Similarly, drug administration in the DMH
changed the heat-evoked activity of RVM Off-like cells (main
effect of the drug: F2,81 = 4.967, P= 0.009) but these differences
did not vary with the experimental group (interaction group x
drug: F2,81 = 2.230, P=0.114), 20 min after administration.
Again, post hoc testing failed to find significant drug treatment-
induced effects on the heat-evoked response of Off-like cells,
except for the increase of response after exogenous GAL treatment
in the SHAM group (Fig. 6D).
Discussion
This study demonstrates, for the first time, a pronociceptive role
for supraspinal GAL, as the administration of this neuropeptide to
the DMH significantly increased spinal nociception (as indicated
by the decrease in PWL) in awake healthy and arthritic animals.
Moreover, the microinjection of GAL receptor agonist/antagonist
in the DMH showed that the exogenous GAL’s pronociceptive
effect was mediated by GALR1 but not GALR2. The analysis of c-
Fos expression revealed the serotonergic RVM and DRN,
particularly in SHAM animals, as caudal areas potentially
involved in signalling this descending pronociceptive effect. The
exogenous GAL-induced increase of c-Fos expression in the RVM
may not be explained by action on RVM On-like or Off-like pain
modulatory cells, as the discharge rates of these two non-
serotonergic cell types remained unaltered during pharmacological
manipulations in the present study.
1. Novel pronociceptive effect of supraspinal GAL
Administration of exogenous GAL into the DMH induced
behavioural hyperalgesia (decreased PWL) in healthy and ARTH
animals. This is a novel effect for GAL as previous studies had only
reported an antinociceptive role of this neuropeptide after its
administration in brain areas involved in pain modulation, such as
the hypothalamic arcuate nucleus [40], central AMY [20] and the
PAG [22]. Thus, and similarly to what is observed at the spinal
cord level [41,42], GAL appears to have a bidirectional role in
supraspinal descending pain modulation depending on the area
where GALRs are activated. The demonstration of a tonic
pronociceptive effect of GAL, by treatment of the DMH with a
non-specific GALR antagonist, supports the proposal that the
pronociceptive effect of GAL was mediated by GALRs.
Figure 5. Brainstem c-Fos expression. Number of c-Fos positive cells in the contralateral (A,C,E) and ipsilateral (B,D,F) sides of the rostral
ventromedial medulla (RVM; A,B), locus coeruleus (LC; C,D), ventrolateral periaqueductal matter (vlPAG; E,F) and dorsal raphe nucleus (DRN; G) after
the administration of saline or exogenous galanin in the dorsomedial nucleus of the hypothalamus (DMH) with and without peripheral noxious
stimulation. Data is presented as mean + SEM. SAL – Saline; GAL – Galanin; SAL+STI – SAL and peripheral noxious stimulation (limb flexion-extension);
GAL+STI – GAL and peripheral noxious stimulation (limb flexion-extension). * indicates significant differences in c-Fos expression when compared to
SAL injection in the DMH; * over line indicates differences in c-Fos expression between experimental groups; # indicates significant differences in c-
Fos expression when compared to GAL injection in the DMH; 1 indicates significant differences in c-Fos expression when compared to the flexion-
extension protocol (*, #P,0.05; **, ##, 11P,0.01; ***, ###, 111P,0.001).
doi:10.1371/journal.pone.0113077.g005
Table 1. Spontaneous and heat-evoked baseline activities of rostral ventromedial medullary (RVM) On- and Off-like cells.
Cell type SHAM ARTH t P
Spontaneous On-like 1.86±0.39 Hz 0.77±0.19 Hz t102 = 2.689 P=0.008**
Off-like 4.77±0.46 Hz 3.37±0.26 Hz t85 = 2.833 P=0.006**
Evoked On-like 2.51±0.31 Hz 2.82±0.37 Hz t102 = 0.601 P=0.549
Off-like -2.45±0.25 Hz -1.72±0.26 Hz t85 = 2.782 P=0.007**
Data presented as mean 6 SEM.
**P,0.01.
doi:10.1371/journal.pone.0113077.t001
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Administration of exogenous GAL in the DMH facilitated
nociception in both ARTH and SHAM animals. This finding
contrasts with the results of previous studies indicating that
exogenous GAL is antinociceptive when administered in the
hypothalamic arcuate nucleus of animals with inflammation [17],
or in the PAG of animals with mononeuropathy [22]. Importantly,
the present results show that the descending GAL-driven pathway
originating in the DMH, unlike the glutamate-driven pathway [9],
remains functional in animals with experimental monoarthritis.
Administration of a non-specific GALR antagonist alone into the
DMH of ARTH animals had no effect on nociception while it
produced antinociception in SHAM controls. This finding suggests
that the GAL-driven pathway descending from the DMH is not
tonically active in ARTH as in SHAM animals, but its activation
in ARTH animals depends on the activation of upstream
pathways inducing the release of GAL in the DMH.
2. GAL-driven nociceptive facilitation is mediated by
GALR1
Further analysis on the contributions of GALR1 and GALR2 to
the pain modulatory role of GAL in the DMH demonstrated that
the facilitatory effect of GAL is mediated by GALR1, a receptor
that couples to the Gi/Go pathway to decrease adenylyl cyclase
activity [43]. Once more, this result contrasts with the available
literature, where the activation of this receptor at spinal and
supraspinal levels is reported to elicit an antinociceptive effect [44–
46]. In fact, in the spinal cord it was GALR2 that has been
reported to have a pronociceptive effect [41]; however, the results
on administration of a GALR2 antagonist in the present study
indicated that endogenous GAL acting on GALR2 had a tonic
antinociceptive action in SHAM animals, whereas blocking
GALR2 did not alter nociception in ARTH animals. Another
possibility would be that the differential distribution of GALR1
and GALR2 receptors in the DMH could contribute to enhance
GALR1-dependent effects, however as demonstrated by Mitchell
and collaborators [47], not only does mRNAs analysis confirm an
overlapping of GAL-R1 and GAL-R2 in the DMH but both
receptors are also highly expressed in this nucleus. On the other
hand, the expression of both receptors in the DMH does not
account per se for the GAL/DMH pronociceptive effect since
these receptors are also highly expressed and overlapping in the
arcuate nuclei, an area where the intracerebral administration of
exogenous GAL promotes antinociception [17]. Overall, it is
probable that the facilitation of nociceptive behaviour by GAL in
the DMH of ARTH animals results (i) from disinhibition of
pronociceptive pathways driven by GALR1 and/or (ii) from a
decrease in the activity of antinociceptive GALR2-driven circuits.
It is also possible that behavioural hyperalgesia in ARTH
animals is reinforced by their emotional-like status. A recent study
from our group [48] showed that animals with experimental
monoarthritis displayed depressive-like behaviour. Interestingly,
Blackshear et al. [24] showed that the intracerebroventricular
injection of GAL and M617 increased c-fos expression in the
DMH and the AMY, a nuclei involved the modulation of the
emotional component of pain. Another work [49] showed that
acute activation of GALR1 promoted the expression of ‘prode-
pressive-like’ behaviours, while GALR2 mediated the ‘antidepres-
sant-like’ effects of GAL. Hence, taking into account that
depressive states heighten pain perception in humans [50] and
rodents [51], the pronociceptive GALR1 and the antinociceptive
GALR2 effects observed in this study may be related to comorbid
mood alterations known to be associated with chronic pain
[52,53].
Figure 6. Spontaneous and noxious-evoked rostral ventromedial medulla (RVM) cell activity after the administration of exogenous
galanin (GAL) or a non-selective GAL receptor antagonist (M40) in the dorsomedial nucleus of the hypothalamus (DMH). Overall, no
changes were observed in the spontaneous (A, B) and noxious-evoked (C, D) activity of RVM pronociceptive On-like (A, C) and antinociceptive Off-
like cells (B,D) before and 20 min after the intracerebral microinjection of exogenous GAL (A–D) and M40 (A–D). Data is presented as mean + SEM.
doi:10.1371/journal.pone.0113077.g006
Role of Supraspinal Galanin in Hyperalgesia in the Rat
PLOS ONE | www.plosone.org 11 November 2014 | Volume 9 | Issue 11 | e113077
3. Activation of serotonergic nuclei is influenced both by
exogenous GAL in the DMH and noxious peripheral
stimulation
The analysis of c-Fos expression was restricted to the VLPAG,
DR, LC and RVM since these areas have been previously
demonstrated to be strongly modulated by the DMH [54–56],
while simultaneously implicated in nociceptive processing [57–59].
The limb extension-induced increase in c-Fos expression in the
VLPAG and RVM of SHAM animals suggests that repetitive
extension of a non-arthritic knee joint for a period of two hours
can be considered a noxious stimulus [60]. In addition, the
increased c-for expression in the VLPAG and RVM also suggests
that repetitive knee joint extension activated the feedback loop of
nociception involving the PAG-RVM-spinal dorsal horn circuitry,
which may either inhibit or facilitate nociception [11,61,62].
Administration of exogenous GAL into the DMH increased the
expression of c-Fos ipsilaterally in the VLPAG and bilaterally in
the RVM, which suggests that DMH neurones expressing GALR
are able to activate descending nociceptive controls. However, our
electrophysiological data shows that exogenous GAL in the DMH
did not alter the activity of RVM On- and Off-cells that are non-
serotonergic pain control neurones. Therefore, we propose that
the RVM cells expressing c-Fos following exogenous GAL
treatment may have been RVM Neutral-cells, a subpopulation
of which are serotonergic [63] and which were not studied in the
present electrophysiological experiment. The fact that the DMH
GAL-driven descending pronociceptive drive is independent of
RVM On- and Off-like cell activity is very interesting in terms of
pain management, since many centrally acting analgesic com-
pounds (opioids, cannabinoids and non-steroidal anti-inflamma-
tory drugs) reduce pain by increasing the discharge rate of
antinociceptive RVM Off-cells and/or by inhibiting the discharge
rate of pronociceptive RVM On-cells [61].
In SHAM animals, repetitive limb extension alone or exogenous
GAL administration alone in the DMH activated the descending
PAG-RVM-spinal cord pathway as revealed by c-Fos expression.
However, application of exogenous GAL simultaneously with
repetitive extension of the limb failed to increase c-Fos expression
in the PAG-RVM circuitry of SHAM animals, suggesting that
together the two stimulation procedures counteracted each other’s
effect, leading to a general inhibition of this circuitry. The
increased c-Fos expression in the RVM by the pronociceptive
exogenous GAL treatment alone might reflect activation of RVM
serotonergic cells. While the serotonergic system has a complex
role in pain control, there is evidence suggesting that the net effect
induced by RVM serotonergic neurones is facilitation of nocicep-
tion [64]. It should be noted here that serotonergic RVM
neurones are not On- or Off- cells [63] that were studied in the
present electrophysiological experiment using noxious heat and
shown not to be influenced by exogenous GAL. We propose that
the GAL-induced descending action may have induced activation
of medullo-spinal serotonergic neurones shown as increased c-Fos
expression in the RVM and resulting in the relay of pronociceptive
action to the spinal cord.
The increased expression of c-Fos in the serotonergic DRN after
limb extensions is in line with a role of this nucleus in ascending
[65] and descending [66] pain modulatory pathways. Similarly,
increased expression of c-Fos of DRN after exogenous GAL in the
DMH is not unexpected as the DMH projects directly to the DRN
[67] and the activity of DRN serotonergic neurones is influenced
by GALR1 present on their soma and proximal dendrites [68]. It
still remains to be studied through which mechanisms the DRN
might be involved in the relay of the descending pronociceptive
effect driven by exogenous GAL in the DMH.
4. Activation of the noradrenergic LC by exogenous GAL
in the DMH and noxious peripheral stimulation varies
between SHAM and ARTH animals
Previous studies have demonstrated that the LC responds to
noxious stimulation, as revealed e.g. by c-Fos expression [69],
while it is a major source of spinal noradrenaline and descending
noradrenergic control of nociception [70,71]. In the present study,
exogenous GAL treatment of DMH alone failed to influence c-Fos
expression of LC in SHAM or ARTH animals. However,
following repetitive limb extensions, c-Fos expression of LC was
increased in SHAM but not ARTH animals. Interestingly, the
peripheral stimulation-induced increase of c-Fos expression in the
LC was predominantly ipsilateral, while ascending nociceptive
signals activate the LC contra- or bilaterally [71]. A potential
explanation for the ipsilaterally increased c-Fos expression after
peripheral stimulation in the present study is that it reflected
activation of descending pain modulation pathways descending
predominantly ipsilaterally rather than processing of the ascending
afferent volley that is expected to be contra- or bilateral. The
DMH has a strong galaninergic output to various brain areas [72],
including the LC [65], and GAL has been shown to decrease
neuronal firing in LC [73]. While these findings suggest that the
DMH may directly modulate activity of the LC, they still leave
open what is the underlying mechanism and functional signif-
icance of the finding that exogenous GAL treatment of the DMH
together with repetitive limb extensions increased c-Fos activity in
the LC of ARTH but not SHAM animals.
5. Influence of arthritis and repetitive limb movement
The increase of c-Fos expression in the VLPAG and to a lesser
extent in the RVM of SAL-treated ARTH animals indicates an
overall increase in the tonic activity of the PAG-RVM-spinal cord
pathways after the induction of experimental monoarthritis, which
is in accordance with the enhancement of descending inhibitory
circuits during chronic inflammation [74–77]. Interestingly, limb
extension in the ARTH group decreased c-Fos expression in the
VLPAG suggesting that acute noxious mechanical stimulation of
the injured knee dampens tonic descending inhibition mediated by
the VLPAG. On the other hand, the increase in c-Fos expression
in the RVM, taking into account that the RVM can either
facilitate or inhibit nociception [78], could indicate that this
nucleus is engaged in descending facilitation during acute noxious
stimulation of ARTH animals, as shown for other chronic pain
disorders [79–81].
Our electrophysiological results showed that before any drug
treatments both the baseline and the peripheral stimulus-evoked
response in antinociceptive RVM Off-like cells were lower in
ARTH than SHAM animals, while there was no difference in the
pre-treatment heat-evoked activity of pronociceptive RVM On-
like neurones of ARTH and SHAM animals. This finding suggests
that a decreased activity of RVM Off-like cells contributes to
hyperalgesia in ARTH animals. However, it does not exclude the
possibility that among descending facilitatory mechanisms con-
tributing to hyperalgesia in ARTH animals were other cell types of
the RVM, in particular medullospinal serotonergic neurones, or
other brainstem nuclei.
Concerning the DRN, the expression of c-Fos after repetitive
limb extensions was increased, when compared with SAL-treated
ARTH animals, but similar to the expression in c-Fos in SHAM
after limb extensions, suggesting that the nociceptive processing
through this pathway is not enhanced after the induction of
experimental monoarthritis. By contrast, it is possible that the
noxious stimulation-evoked activation of the LC is impaired in
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ARTH animals, since c-Fos expression was decreased when
compared to SHAM animals after limb extensions and unaltered
when compared to SAL-treated ARTH animals.
Without noxious stimulation, exogenous GAL in the DMH of
ARTH animals appeared to dampen tonic descending inhibition
(as indicated by decreased c-Fos expression in the VLPAG) while it
enhanced the tonic activity of pronociceptive serotonergic
(indicated by increased c-Fos expression in the DRN and
RVM), but not noradrenergic (unaltered c-Fos expression in the
LC) circuits. However, when combined with limb extensions, both
tonic descending inhibition (decreased c-Fos expression in the
VLPAG) and the activity of pronociceptive serotonergic areas
(decreased c-Fos expression in the RVM and DRN) were
diminished. This finding indicates that in ARTH animals,
exogenous GAL in the DMH exerts differential effects under
basal and noxious stimulation-evoked conditions. A differential
effect has also been reported while studying the role of GAL in the
presence/absence of stress [49].
By contrast, only the combination of exogenous GAL injection
in the DMH and limb stimulation was able to enhance the activity
of the noradrenergic pain system as evidenced by the strong
increase of c-Fos expression in the LC. Although noradrenergic
pathways were up to recently considered to exert mostly inhibitory
influences on spinal nociception, Hickey and collegues [59]
recently demonstrated that a specific subpopulation of LC
neurones enhances the processing of nociceptive information
and could thus partly contribute to behavioural hyperalgesia in
chronic inflammation. Further studies are needed to find out
whether LC is involved in mediating the descending pronocicep-
tive effect elicited by exogenous GAL in the DMH.
Conclusions
In the present study, we demonstrate a pronociceptive GALR1-
mediated role for hypothalamic GAL in experimental monoar-
thritis. Exogenous GAL in the DMH appeared to exert differential
effects upon the brainstem pain modulatory areas; the effect varied
between the experimental group (healthy or arthritic animals),
brainstem nucleus (PAG, RVM, DRN, or LC), and the presence
or absence of concomitant noxious stimulation. Finally, the results
suggest that further studies evaluating the potential applicability of
GALR1 antagonists in the control of chronic inflammatory pain
are needed.
Author Contributions
Conceived and designed the experiments: DA FPR. Performed the
experiments: DA ADP PM SP PR. Analyzed the data: DA PC.
Contributed reagents/materials/analysis tools: AA. Wrote the paper: DA
FPR. Revised the manuscript: AP AA.
References
1. Jimenez-Andrade JM, Zhou S, Du J, Yamani A, Grady JJ, et al. (2004) Pro-
nociceptive role of peripheral galanin in inflammatory pain. Pain 110: 10–21.
2. Liu HX, Ho¨kfelt TG (2002) The participation of galanin in pain processing at
the spinal level. Trends Pharmacol Sci 23: 468–474.
3. Reeve AJ, Walker K, Urban L, Fox A (2000) Excitatory effects of galanin in the
spinal cord of intact, anaesthetized rats. Neurosci Lett 295: 25–28.
4. Yue H, Fujita T, Kumamoto E (2011) Biphasic modulation by galanin of
excitatory synaptic transmission in substantia gelatinosa neurons of adult rat
spinal cord slices. J Neurophysiol 105: 2337–2349.
5. Brumovsky P, Mennicken F, O’Donnell D, Ho¨kfelt T (2006) Differential
distribution and regulation of galanin receptors- 1 and -2 in the rat lumbar spinal
cord. Brain Res 1085: 111–120.
6. Ch’ng JL, Christofides ND, Anand P, Gibson SJ, Allen YS, et al. (1985)
Distribution of galanin immunoreactivity in the central nervous system and the
responses of galanin-containing neuronal pathways to injury. Neuroscience 16:
343–354.
7. Millan MJ (2002) Descending control of pain. Prog Neurobiol 66: 355–474.
8. Pinto-Ribeiro F, Ansah OB, Almeida A, Pertovaara A (2008) Influence of
arthritis on descending modulation of nociception from the paraventricular
nucleus of the hypothalamus. Brain Res 1197: 63–75.
9. Pinto-Ribeiro F, Amorim D, David-Pereira A, Monteiro AM, Costa P, et al.
(2013) Pronociception from the dorsomedial nucleus of the hypothalamus is
mediated by the rostral ventromedial medulla in healthy controls but is absent in
arthritic animals. Brain Res Bull 99: 100–108.
10. Pertovaara A, Almeida A (2006) Descending inhibitory systems. In: Cervero F,
Jensen T, (eds) Handbook of Clinical Neurology, 3rd series, Elsevier,
Amsterdam, pp 179–192.
11. Almeida A, Leite-Almeida H, Tavares I (2006) Medullary control of nociceptive
transmission: reciprocal dual communication with the spinal cord. Drug Discov
Today Dis Mech 3: 305–312.
12. Lu X, Lundstro¨m L, Langel U¨, Bartfai T (2005) Galanin receptor ligands.
Neuropeptides 39: 143–146.
13. Mitchell V, Habert-Ortoli E, Epelbaum J, Aubert J, Beauvillain JC (1997)
Semiquantitative distribution of galanin-receptor (GAL-R1) mRNA-containing
cells in the male rat hypothalamus. Neuroendocrinology 66: 160–172.
14. Waters SM, Krause JE (2000) Distribution of galanin-1, -2 and -3 receptor
messenger RNAs in central and peripheral rat tissues. Neuroscience 29: 265–
271.
15. Webling KE, Runesson J, Bartfai T, Langel U¨ (2012) Galanin receptors and
ligands. Front Endocrinol 3: 146.
16. Mennicken F, Hoffert C, Pelletier M, Ahmad S, O’Donnell D (2002) Restricted
distribution of galanin receptor 3 (GalR3) mRNA in the adult rat central nervous
system. J Chem Neuroanat 24: 257–268.
17. Sun YG, Gu XL, Lundeberg T, Yu LC (2003) An antinociceptive role of galanin
in the arcuate nucleus of hypothalamus in intact rats and rats with inflammation.
Pain 106: 143–150.
18. Sun YG, Li J, Yang BN, Yu LC (2004) Antinociceptive effects of galanin in the
rat tuberomammillary nucleus and the plasticity of galanin receptor 1 during
hyperalgesia. J Neurosci Res 77: 718–722.
19. Xu SL, Li J, Zhang JJ, Yu LC (2012) Antinociceptive effects of galanin in the
nucleus accumbens of rats. Neurosci Lett 520: 43–46.
20. Jin WY, Liu Z, Liu D, Yu LC (2010) Antinociceptive effects of galanin in the
central nucleus of amygdala of rats, an involvement of opioid receptors. Brain
Res 1320: 16–21.
21. Li J, Zhang JJ, Xu SL, Yu LC (2012) Antinociceptive effects induced by injection
of the galanin receptor 1 agonist M617 into central nucleus of amygdala in rats.
Neurosci Lett 526: 45–48.
22. Wang D, Lundeberg T, Yu LC (2000) Antinociceptive role of galanin in
periaqueductal grey of rats with experimentally induced mononeuropathy.
Neuroscience 96: 767–771.
23. Kong Q, Yu LC (2013) Antinociceptive effects induced by intra-periaqueductal
grey injection of the galanin receptor 1 agonist M617 in rats with morphine
tolerance. Neurosci Lett: 4–7.
24. Blackshear A, Yamamoto M, Anderson BJ, Holmes PV, Lundstro¨m L, et al.
(2007) Intracerebroventricular administration of galanin or galanin receptor
subtype 1 agonist M617 induces c-Fos activation in central amygdala and
dorsomedial. hypothalamus. Peptides 28: 1120–1124.
25. Martenson ME, Cetas JS, Heinricher MM (2009) A possible neural basis for
stress-induced hyperalgesia. Pain 142: 236–244.
26. Ansah OB, Pertovaara A (2007) Peripheral suppression of arthritic pain by
intraarticular fadolmidine, an alpha 2-adrenoceptor agonist, in the rat. Anesth
Analg 105: 245–250.
27. Radhakrishnan R, Moore SA, Sluka KA (2003) Unilateral carrageenan injection
into muscle or joint induces chronic bilateral hyperalgesia in rats. Pain 104: 567–
577.
28. Randall L, Selitto J (1957) A method for measurement of analgesic activity on
inflamed tissue. Arch Int Pharmacodyn The´rapie 111: 409–419.
29. Rivat C, Richebe´ P, Laboureyras E, Laulin JP, Havouis R, et al. (2008)
Polyamine deficient diet to relieve pain hypersensitivity. Pain 137: 125–137.
30. Barton NJ, Strickland IT, Bond SM, Brash HM, Bate ST, et al. (2007) Pressure
application measurement (PAM): a novel behavioural technique for measuring
hypersensitivity in a rat model of joint pain. J Neurosci Methods 163: 67–75.
31. Hargreaves K, Dubner R, Brown F, Flores C, Joris J (1988) A new and sensitive
method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:
77–88.
32. Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates. 6th ed.
Elsevier Inc.
33. Myers RD (1966) Injection of solutions into cerebral tissue: Relation between
volume and diffusion. Physiol Behav 1: 171–174.
34. Sun YG, Gu XL, Yu LC (2007) The neural pathway of galanin in the
hypothalamic arcuate nucleus of rats: Activation of beta-endorphinergic neurons
projecting to periaqueductal gray matter. J Neurosci Res 85: 2400–2406.
Role of Supraspinal Galanin in Hyperalgesia in the Rat
PLOS ONE | www.plosone.org 13 November 2014 | Volume 9 | Issue 11 | e113077
35. Fields HL, Bry J, Hentall I, Zorman G (1983) The activity of neurons in the
rostral medulla of the rat during withdrawal from noxious heat. J Neurosci 3:
2545–2552.
36. Fields H, Heinricher MM (1985) Anatomy and physiology of a nociceptive
modulatory system. Philos Trans R Soc Lond B Biol Sci 308: 361–374.
37. Sanoja R, Tortorici V, Fernandez C, Price TJ, Cervero F (2010) Role of RVM
neurons in capsaicin-evoked visceral nociception and referred hyperalgesia.
Eur J Pain 14: 120.e1–9.
38. Song Z, Ansah OB, Meyerson BA, Pertovaara A, Linderoth B (2013) The
rostroventromedial medulla is engaged in the effects of spinal cord stimulation in
a rodent model of neuropathic pain. Neuroscience 247: 134–144.
39. Morgado C, Tavares I (2007) C-fos expression at the spinal dorsal horn of
streptozotocin-induced diabetic rats. Diabetes Metab Res Rev 23: 644–652.
40. Gu XL, Sun YG, Yu LC (2007) Involvement of galanin in nociceptive regulation
in the arcuate nucleus of hypothalamus in rats with mononeuropathy. Behav
Brain Res 179: 331–335.
41. Liu H, Brumovsky P, Schmidt R, Brown W, Payza K, et al. (2001) Receptor
subtype-specific pronociceptive and analgesic actions of galanin in the spinal
cord: selective actions via GalR1 and GalR2 receptors. Proc Natl Acad
Sci U S A 98: 9960–9964.
42. Hulse RP, Donaldson LF, Wynick D (2012) Differential roles of galanin on
mechanical and cooling responses at the primary afferent nociceptor. Mol Pain
8: 41.
43. Wang S, Hashemi T, Fried S, Clemmons AL, Hawes BE (1998) Differential
intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes.
Biochemistry 37: 6711–6717.
44. Blakeman KH, Hao JX, Xu XJ, Jacoby AS, Shine J, et al. (2003) Hyperalgesia
and increased neuropathic pain-like response in mice lacking galanin receptor 1
receptors. Neuroscience 117: 221–227.
45. Hua XY, Hayes CS, Hofer A, Fitzsimmons B, Kilk K, et al. (2004) Galanin acts
at GalR1 receptors in spinal antinociception: synergy with morphine and AP-5.
J Pharmacol Exp Ther 308: 574–582.
46. Fu LB, Wanga XB, Jiao S, Wua X, Yua LC (2011) Antinociceptive effects of
intracerebroventricular injection of the galanin receptor 1 agonist M 617 in rats.
Neurosci Lett 491: 174–176.
47. Mitchell V, Bouret S, Howard AD, Beauvillain JC (1999) Expression of the
galanin receptor subtype Gal-R2 mRNA in the rat hypothalamus. J Chem
Neuroanat 16: 265–277.
48. Amorim D, David-Pereira A, Pertovaara A, Almeida A, Pinto-Ribeiro F (2014)
Amitriptyline reverses hyperalgesia and improves associated mood-like disorders
in a model of experimental monoarthritis. Behav Brain Res 265: 12–21.
49. Kuteeva E, Wardi T, Lundstro¨m L, Sollenberg U, Langel U¨, et al. (2008)
Differential role of galanin receptors in the regulation of depression-like behavior
and monoamine/stress-related genes at the cell body level. Neuropsychophar-
macology 33: 2573–2585.
50. Murphy LB, Sacks JJ, Brady TJ, Hootman JM, Chapman DP (2012) Anxiety
and depression among US adults with arthritis: prevalence and correlates.
Arthritis Care Res (Hoboken) 64: 968–976.
51. Wang S, Tian Y, Song L, Lim G, Tan Y, et al. (2012) Exacerbated mechanical
hyperalgesia in rats with genetically predisposed depressive behavior: role of
melatonin and NMDA receptors. Pain 153: 2448–2457.
52. Verdu B, Decosterd I, Buclin T, Stiefel F, Berney A (2008) Antidepressants for
the treatment of chronic pain. Drugs 68: 2611–2632.
53. Neugebauer V, Galhardo V, Maione S, Mackey SC (2009) Forebrain Pain
Mechanisms. Brain Res Rev 60: 226–242.
54. Johnson P, Lowry C, Truitt W, Shekhar A (2008) Disruption of GABAergic tone
in the dorsomedial hypothalamus attenuates responses in a subset of serotonergic
neurons in the dorsal raphe nucleus following lactate-induced panic.
J Psycopharmacology 22: 642–652.
55. Aston-Jones G, Chen S, Zhu Y, Oshinsky M (2001) A neural circuit for circadian
regulation of arousal. Nat Neurosci 4: 732–738.
56. Wagner KM, Roeder Z, Desrochers K, Buhler AV, Heinricher MM, et al.
(2013) The dorsomedial hypothalamus mediates stress-induced hyperalgesia and
is the source of the pronociceptive peptide cholecystokinin in the rostral
ventromedial medulla. Neuroscience 238: 29–38.
57. Wang QP, Nakai Y (1994) The dorsal raphe: an important nucleus in pain
modulation. Brain Res Bull 34: 575–585.
58. De Luca MC, Branda˜o ML, Motta VA, Landeira-Fernandez J (2003)
Antinociception induced by stimulation of ventrolateral periaqueductal gray at
the freezing threshold is regulated by opioid and 5-HT2A receptors as assessed
by the tail-flick and formalin tests. Pharmacol Biochem Behav 75: 459–466.
59. Hickey L, Li Y, Fyson SJ, Watson TC, Perrins R, et al. (2014) Optoactivation of
locus ceruleus neurons evokes bidirectional changes in thermal nociception in
rats. J Neurosci 34: 4148–4160.
60. Galba´n CJ, Ling SM, Taub DD, Gurkan I, Fishbein KW, et al. (2007) Effects of
knee injection on skeletal muscle metabolism and contractile force in rats.
Osteoarthr Cartil 15: 550–558.
61. Ossipov MH, Dussor GO, Porreca F (2010) Central modulation of pain. J Clin
Invest 120: 3779–3787.
62. Heinricher MM, Tavares I, Leith JL, Lumb BM (2009) Descending control of
nociception: Specificity, recruitment and plasticity. Brain Res Rev 60: 214–225.
63. Potrebic SB, Fields HL, Mason P (1994) Serotonin immunoreactivity is
contained in one physiological cell class in the rat rostral ventromedial medulla.
J Neurosci 14: 1655–1665.
64. Wei F, Dubner R, Zou S, Ren K, Bai G, et al. (2010) Molecular depletion of
descending serotonin unmasks its novel facilitatory role in the development of
persistent pain. J Neurosci 30: 8624–8636.
65. Qiao JT, Dafny N (1988) Dorsal raphe stimulation modulates nociceptive
responses in thalamic parafascicular neurons via an ascending pathway: further
studies on ascending pain modulation pathways. Pain 34: 65–74.
66. Prado WA, Faganello FA (2000) The anterior pretectal nucleus participates as a
relay station in the glutamate-, but not morphine-induced antinociception from
the dorsal raphe nucleus in rats. Pain 88: 169–176.
67. ter Horst G, Luiten P (1986) The projections of the dorsomedial hypothalamic
nucleus in the rat. Brain Res Bull 16: 231–248.
68. Larm JA, Shen PJ, Gundlach AL (2003) Differential galanin receptor-1 and
galanin expression by 5-HT neurons in dorsal raphe´ nucleus of rat and mouse:
evidence for species-dependent modulation of serotonin transmission. Eur -
J Neurosci 17: 481–493.
69. Voisin DL, Guy N, Chalus M, Dallel R (2005) Nociceptive stimulation activates
locus coeruleus neurones projecting to the somatosensory thalamus in the rat.
J Physiol 566: 929–937.
70. Jones SL (1991) Descending noradrenergic influences on pain. Prog Brain Res
88: 381–394.
71. Pertovaara A (2006) Noradrenergic pain modulation. Prog Neurobiol 80: 53–83.
72. Jacobowitz DM, Kresse A, Skofitsch G (2004) Galanin in the brain:
chemoarchitectonics and brain cartography - a historical review. Peptides 25:
433–464.
73. Sevcik J, Finta EP, Illes P (1993) Galanin receptors inhibit the spontaneous firing
of locus coeruleus neurones and interact with mu-opioid receptors. Eur J Phar-
macol 230: 223–230.
74. Ren K, Dubner R (2002) Descending modulation in persistent pain: an update.
Pain 100: 1–6.
75. Cervero F, Schaible HG, Schmidt RF (1991) Tonic descending inhibition of
spinal cord neurones driven by joint afferents in normal cats and in cats with an
inflamed knee joint. Exp Brain Res 83: 675–678.
76. Ren K, Dubner R (1996) Enhanced descending modulation of nociception in
rats with persistent hindpaw inflammation. J Neurophysiol 76: 3025–3037.
77. Terayama R, Guan Y, Dubner R, Ren K (2000) Activity-induced plasticity in
brain stem pain modulatory circuitry after inflammation. Neuro Rep 26: 1915–
1919.
78. Heinricher MM, Barbaro NM, Fields HL (1989) Putative nociceptive
modulating neurons in the rostral ventromedial medulla of the rat: firing of
on- and off-cells is related to nociceptive responsiveness. Somatosens Mot Res 6:
427–439.
79. Porreca F, Ossipov MH, Gebhart GF (2002) Chronic pain and medullary
descending facilitation. Trends Neurosci 25: 319–325.
80. Herrero JF, Cervero F (1996) Supraspinal influences on the facilitation of rat
nociceptive reflexes induced by carrageenan monoarthritis. Neurosci Lett 209:
21–24.
81. Kovelowski CJ, Ossipov MH, Sun H, Lai J, Malan TP, et al. (2000) Supraspinal
cholecystokinin may drive tonic descending facilitation mechanisms to maintain
neuropathic pain in the rat. Pain 87: 265–273.
Role of Supraspinal Galanin in Hyperalgesia in the Rat
PLOS ONE | www.plosone.org 14 November 2014 | Volume 9 | Issue 11 | e113077
